Tarbox Family Office’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Tarbox Family Office’s Portfolio PGNX Stock Details PGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-175	Closed	-$1K	–	1285
2020 Q1	$1K	Buy	+175	New	+$754	﹤0.01%	1088

Other funds holding PGNX

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Tarbox Family Office's PGNX Position: Q2 2020 in Review

Tarbox Family Office sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 175 shares — an estimated $1K sold.

Tarbox Family Office first reported a position in PGNX in Q1 2020 and held it in 1 quarter. The position peaked at $1K in Q1 2020. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

Tarbox Family Office reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
Tarbox Family Office sold 175 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $1K.
Tarbox Family Office first reported a position in Progenics Pharmaceuticals Inc in Q1 2020 and held it in 1 quarter.
Tarbox Family Office's Progenics Pharmaceuticals Inc position peaked at $1K in Q1 2020.
3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on Tarbox Family Office's 13F filing for Q2 2020, filed 23 Jul 2020.